- Funding Opportunities From the National Institute of Diabetes and Digestive and Kidney Diseases
10:00 AM - 12:00 PM
Funding Opportunities From the National Institute of Diabetes and Digestive and Kidney Diseases
November 03, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Training and Career Development Programs From the National Institute of Diabetes and Digestive and Kidney Diseases
10:00 AM - 12:00 PM
Training and Career Development Programs From the National Institute of Diabetes and Digestive and Kidney Diseases
November 03, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Resources for Clinical and Epidemiology Research From the National Institute of Diabetes and Digestive and Kidney Diseases
10:00 AM - 12:00 PM
Resources for Clinical and Epidemiology Research From the National Institute of Diabetes and Digestive and Kidney Diseases
November 03, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Initiatives and Resources to Promote Diversity, Equity, and Inclusion at the National Institute of Diabetes and Digestive and Kidney Diseases
10:00 AM - 12:00 PM
Initiatives and Resources to Promote Diversity, Equity, and Inclusion at the National Institute of Diabetes and Digestive and Kidney Diseases
November 03, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- AKINow Recovery Workgroup: Identifying Gaps in Care Post AKI
10:00 AM - 12:00 PM
AKINow Recovery Workgroup: Identifying Gaps in Care Post AKI
November 03, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- From Bench to Bedside: The Developing Initiatives From the AKINow Basic Science Workgroup
10:00 AM - 12:00 PM
From Bench to Bedside: The Developing Initiatives From the AKINow Basic Science Workgroup
November 03, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- UAB-UCSD O'Brien Center for AKI Research
10:00 AM - 12:00 PM
UAB-UCSD O'Brien Center for AKI Research
November 03, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- The Kidney Precision Medicine Project (KPMP)
10:00 AM - 12:00 PM
The Kidney Precision Medicine Project (KPMP)
November 03, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Adult Immunization Project: Joining Process and Quality Improvement Practices to Optimize Vaccination Rates in Patients With Kidney Disease
10:00 AM - 12:00 PM
Adult Immunization Project: Joining Process and Quality Improvement Practices to Optimize Vaccination Rates in Patients With Kidney Disease
November 03, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Design and Rationale of FINE-REAL: A Prospective Study Providing Insights Into the Use of Finerenone in Routine Clinical Settings
10:00 AM - 12:00 PM
Design and Rationale of FINE-REAL: A Prospective Study Providing Insights Into the Use of Finerenone in Routine Clinical Settings
November 03, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Study Design of a Phase 2 Trial of the Aldosterone Synthase Inhibitor BI 690517 Alone and in Combination With Empagliflozin in Patients With Diabetic and Non-Diabetic CKD
10:00 AM - 12:00 PM
Study Design of a Phase 2 Trial of the Aldosterone Synthase Inhibitor BI 690517 Alone and in Combination With Empagliflozin in Patients With Diabetic and Non-Diabetic CKD
November 03, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- NUGoKidney Research Cores: Paving the Way for Breakthroughs in Kidney Therapeutics
10:00 AM - 12:00 PM
NUGoKidney Research Cores: Paving the Way for Breakthroughs in Kidney Therapeutics
November 03, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- A National Registry for People With All Stages and Types of Kidney Disease: The National Kidney Foundation (NKF) Patient Network
10:00 AM - 12:00 PM
A National Registry for People With All Stages and Types of Kidney Disease: The National Kidney Foundation (NKF) Patient Network
November 03, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Development of a Curriculum to Train Exercise and Healthcare Professionals to Implement Exercise Programs in CKD
10:00 AM - 12:00 PM
Development of a Curriculum to Train Exercise and Healthcare Professionals to Implement Exercise Programs in CKD
November 03, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Pittsburgh Center for Kidney Research: A George M. O'Brien Kidney Research Core Center
10:00 AM - 12:00 PM
Pittsburgh Center for Kidney Research: A George M. O'Brien Kidney Research Core Center
November 03, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Concentrated Action for Long-Term Safety of SGLT2 Inhibitors in Alport Syndrome: Guard Alport
10:00 AM - 12:00 PM
Concentrated Action for Long-Term Safety of SGLT2 Inhibitors in Alport Syndrome: Guard Alport
November 03, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Mayo Clinic Translational Polycystic Kidney Disease Center (MTPC)
10:00 AM - 12:00 PM
Mayo Clinic Translational Polycystic Kidney Disease Center (MTPC)
November 03, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Methodology of the POSITANO Clinical Trial: Assessing the Efficacy and Safety of Octreotide Subcutaneous Depot CAM2029 in Patients With Symptomatic Polycystic Liver Disease
10:00 AM - 12:00 PM
Methodology of the POSITANO Clinical Trial: Assessing the Efficacy and Safety of Octreotide Subcutaneous Depot CAM2029 in Patients With Symptomatic Polycystic Liver Disease
November 03, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Two Phase 3 Trials Evaluating Crovalimab in Patients With Atypical Haemolytic Uraemic Syndrome (aHUS): COMMUTE-a and COMMUTE-p
10:00 AM - 12:00 PM
Two Phase 3 Trials Evaluating Crovalimab in Patients With Atypical Haemolytic Uraemic Syndrome (aHUS): COMMUTE-a and COMMUTE-p
November 03, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- The Polycystic Kidney Disease Research Resource Consortium (PKD-RRC)
10:00 AM - 12:00 PM
The Polycystic Kidney Disease Research Resource Consortium (PKD-RRC)
November 03, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Autosomal Dominant Tubulointerstitial Kidney Disease (ADTKD) Registry, Free Genetic Testing
10:00 AM - 12:00 PM
Autosomal Dominant Tubulointerstitial Kidney Disease (ADTKD) Registry, Free Genetic Testing
November 03, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- George M. O'Brien Kidney Center at Yale
10:00 AM - 12:00 PM
George M. O'Brien Kidney Center at Yale
November 03, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- The Michigan O'Brien Kidney Translational Research Center: Transforming Translational Kidney Research Through Systems Biology
10:00 AM - 12:00 PM
The Michigan O'Brien Kidney Translational Research Center: Transforming Translational Kidney Research Through Systems Biology
November 03, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Community APOL1 Research Engagement (CARE)
10:00 AM - 12:00 PM
Community APOL1 Research Engagement (CARE)
November 03, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- A Phase 2a Trial of VIB4920 for Active Lupus Nephritis (VIBRANT)
10:00 AM - 12:00 PM
A Phase 2a Trial of VIB4920 for Active Lupus Nephritis (VIBRANT)
November 03, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- FOrMe, the German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry: An Update
10:00 AM - 12:00 PM
FOrMe, the German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry: An Update
November 03, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Atrasentan in Patients With IgA Nephropathy: The ALIGN Study
10:00 AM - 12:00 PM
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Atrasentan in Patients With IgA Nephropathy: The ALIGN Study
November 03, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- A Phase 1/2 Multicenter Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BION-1301 in Healthy Volunteers and Adults With IgA Nephropathy
10:00 AM - 12:00 PM
A Phase 1/2 Multicenter Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BION-1301 in Healthy Volunteers and Adults With IgA Nephropathy
November 03, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Study Design of a Phase 2a trial of BI 764198, a Transient Receptor Potential Channel 6 (TRPC6) Inhibitor, in Focal Segmental Glomerulosclerosis
10:00 AM - 12:00 PM
Study Design of a Phase 2a trial of BI 764198, a Transient Receptor Potential Channel 6 (TRPC6) Inhibitor, in Focal Segmental Glomerulosclerosis
November 03, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- The Nephrotic Syndrome Study Network (NEPTUNE)
10:00 AM - 12:00 PM
The Nephrotic Syndrome Study Network (NEPTUNE)
November 03, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Atrasentan in Patients With Proteinuric Glomerular Diseases: The AFFINITY Study
10:00 AM - 12:00 PM
Atrasentan in Patients With Proteinuric Glomerular Diseases: The AFFINITY Study
November 03, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Efficacy of Belimumab and Rituximab Compared to Rituximab Alone for the Treatment of Primary Membranous Nephropathy (REBOOT)
10:00 AM - 12:00 PM
Efficacy of Belimumab and Rituximab Compared to Rituximab Alone for the Treatment of Primary Membranous Nephropathy (REBOOT)
November 03, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- A Phase 2 Study Evaluating the Efficacy and Safety of ALXN2050, a Complement Factor D inhibitor, in Patients With IgA Nephropathy (IgAN) or Proliferative Lupus Nephritis (LN)
10:00 AM - 12:00 PM
A Phase 2 Study Evaluating the Efficacy and Safety of ALXN2050, a Complement Factor D inhibitor, in Patients With IgA Nephropathy (IgAN) or Proliferative Lupus Nephritis (LN)
November 03, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- A Phase 2 Study Evaluating the Efficacy and Safety of Ravulizumab in Patients With IgA Nephropathy (IgAN) or Proliferative Lupus Nephritis (LN)
10:00 AM - 12:00 PM
A Phase 2 Study Evaluating the Efficacy and Safety of Ravulizumab in Patients With IgA Nephropathy (IgAN) or Proliferative Lupus Nephritis (LN)
November 03, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- A Phase 3, Randomized, Multicenter Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Treatment of Complement 3 Glomerulopathy or Immune Complex Membranoproliferative Glomerulonephritis
10:00 AM - 12:00 PM
A Phase 3, Randomized, Multicenter Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Treatment of Complement 3 Glomerulopathy or Immune Complex Membranoproliferative Glomerulonephritis
November 03, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Enlight-LN: A Prospective Observational Registry of Patients Treated With Voclosporin for Lupus Nephritis in the United States
10:00 AM - 12:00 PM
Enlight-LN: A Prospective Observational Registry of Patients Treated With Voclosporin for Lupus Nephritis in the United States
November 03, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- ACTION3 Pivotal Phase 3 Study Assessing the CCR2 Inhibitor DMX-200 (Repagermanium) in Adult Patients With Focal Segmental Glomerulosclerosis (FSGS)
10:00 AM - 12:00 PM
ACTION3 Pivotal Phase 3 Study Assessing the CCR2 Inhibitor DMX-200 (Repagermanium) in Adult Patients With Focal Segmental Glomerulosclerosis (FSGS)
November 03, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- The Indiana O'Brien Center for Advanced Renal Microscopy and Analysis
10:00 AM - 12:00 PM
The Indiana O'Brien Center for Advanced Renal Microscopy and Analysis
November 03, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- A Dose Escalation and Proof-of-Concept Study of REGN5459 or REGN5458 (BCMAxCD3 Bispecific Antibodies) for Desensitization of Hemodialysis Patients Who Are Highly Sensitized to Human Leukocyte Antigen
10:00 AM - 12:00 PM
A Dose Escalation and Proof-of-Concept Study of REGN5459 or REGN5458 (BCMAxCD3 Bispecific Antibodies) for Desensitization of Hemodialysis Patients Who Are Highly Sensitized to Human Leukocyte Antigen
November 03, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Clinical Utility of the OmniGraf Biomarker Panel in the Care of Kidney Transplant Recipients (CLARITY) Trial
10:00 AM - 12:00 PM
Clinical Utility of the OmniGraf Biomarker Panel in the Care of Kidney Transplant Recipients (CLARITY) Trial
November 03, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
